Get To Know Us

Who Are We?

Read More

Visit Our Sites

Where do we work?

Read More

Health Research:

What We Do Differently

Read More

Health Research:

Our Portfolio

Read More

Care Programs:

Our Unique Approach

Read More

What Sets Us Apart

Community:

Read More

Our youth programs

Community:

Read More
Executive Director, Prof. Philippa Musoke

Executive Director’s Message

Greetings

Our mission is to improve the health status of families infected and affected by HIV/AIDS through research, training, prevention and care.

Announcements

Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial

April, 2023

Isoniazid preventive therapy (IPT) initiation during pregnancy was associated with increased incidence of adverse pregnancy outcomes in the TB APPRISE trial. Effects of in utero IPT exposure on infant growth are unknown. Co-author  Dr. Deo Wabwire contributes to this analysis of data from the TB APPRISE (IMPAACT P1078)  trial in eight countries with high tuberculosis prevalence. Click here to read the article.

Experiences and challenges of using community health worker‑led mechanism in supporting HIV disclosure among adults
living with HIV in heterosexual relationships in the rural Uganda

March 11, 2023

HIV status disclosure among sexual partners is vital in HIV management. Community health workers support HIV disclosure among adults living with HIV  in sexual relationships with disclosure difficulties. Dr. Zubair Lukyamuzi writes about the experiences faced in using this model in rural Uganda. Click here to read the article.

Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested casecontrol study

January 23, 2023

Antiretroviral therapy (ART) is associated with high rates of adverse birth outcomes, including preterm birth and low birthweight. Studies suggest that progesterone and prolactin may play important intermediary roles.  Click here to read more on this data analysis from the PROMISE trial in an article co-authored by Dr. Maxensia Owor. 

HIV genotypic resistance among pregnant women initiating ART in Uganda: a baseline evaluation of participants in the Option B+ clinical trial

December 28, 2022

Pre-treatment HIV drug resistance is a threat to elimination of mother to child HIV transmission and could lead to virological failure among HIV-positive pregnant women. Dr. Alexander Amone et al  analyze the  genotypic HIV drug resistance (HIVDR) of baseline samples of participants enrolled in the Option B+ clinical trial in Uganda. Click here to read the article.

Our Work

https://www.mujhu.org/wp-content/uploads/2022/03/01-research.png
https://www.mujhu.org/wp-content/uploads/2022/03/Programs.png
https://www.mujhu.org/wp-content/uploads/2022/03/03-Capacity-building.png
https://www.mujhu.org/wp-content/uploads/2023/03/Group-52.png
https://www.mujhu.org/wp-content/uploads/2022/03/05-corporate-social-responsibility.png

Latest Stories

Featured News Staff Spotlight

Meet our New Internal Auditor

Meet our New Internal Auditor   Ronald Dongo is a Certified Public Accountant, a Certified Internal Auditor, and an ISO...
Read More
Featured News

World Birth Defects Day 2023

Birth defects are an under-recognized health problem. Here are prevention and treatment tips.
Read More
Featured News

Implementing Vaccine Clinical Trial in Pregnant Women: Lessons learnt from the WoMANPOWER vaccine trial.

The WoMANPOWER study is a vaccine clinical trial that was conducted among pregnant women.
Read More
Featured News

No safety concerns seen with use of dapivirine vaginal ring during third trimester of pregnancy, according to interim results of DELIVER study

‘So far, so good’; Results of first two cohorts reported as third and final cohort is ongoing.
Read More
Featured News Staff Spotlight

Graduation News!

This week's graduations from Makerere University Kampala. We have new Master graduates in our ranks!
Read More
Featured News

Pictorial- Birth Defects Surveillance Study Quarterly Meeting

Our just concluded Birth Defects Surveillance - quarterly progress meeting, in pictures.
Read More
Featured News

Press release – End of Ebola, Uganda

Brazzaville/Kampala, 11 January 2023 – Uganda today declared the end of the Ebola disease outbreak.
Read More
Featured Life at MUJHU News

2022 Long Service Awards

Pictorial | We celebrate staff members who have been with us for the past 5, 10, 15, 20, 25 and...
Read More
Featured News

PRESS RELEASE | Tuberculosis: Children with severe pneumonia should be screened systematically for tuberculosis in high incidence countries

PRESS RELEASE Tuberculosis affects 1 million children each year; less than half of them are diagnosed and treated for the...
Read More
Featured Life at MUJHU News

2022 Nurses Day Celebrations

Highlights of the 2022 MU-JHU Nurses Day festivities featuring fashion, games and merry-making.
Read More

Our Partners